Osteochondral regeneration of the femoral medial condyle by using a scaffold-free 3D construct of synovial membrane-derived mesenchymal stem cells in horses.
Authors: Murata Daiki, Ishikawa Shingo, Sunaga Takafumi, Saito Yasuo, Sogawa Takeshi, Nakayama Koichi, Hobo Seiji, Hatazoe Takashi
Journal: BMC veterinary research
Summary
# Regenerating Articular Cartilage and Subchondral Bone Using Stem Cell Constructs in Horses Subchondral bone cysts remain a significant challenge in equine orthopaedics, yet current interventions offer limited biological repair of the overlying articular cartilage. Japanese researchers cultured synovial membrane-derived mesenchymal stem cells from three ponies and assembled them into scaffold-free three-dimensional constructs containing approximately 5.76 × 10⁷ cells total, organised as roughly 1920 spheroids. These constructs were implanted into standardised osteochondral defects created in the femoral medial condyle, with the opposite limb serving as an untreated control. Over six months, treated defects demonstrated substantially better outcomes than controls across multiple assessment modalities: lower radiolucent volumes on computed tomography, superior cartilage repair tissue scores on MRI (using the modified MOCART grading system), and significantly higher gross and histological scores according to ICRS criteria. The practical significance of this work lies in its demonstration that biologically active cell constructs can achieve genuine structural regeneration of both cartilage and bone rather than merely fibrocartilaginous repair, potentially offering a more durable solution than current palliative treatments for this career-limiting condition. Whilst further work is needed to establish clinical efficacy, dosing protocols, and applicability across different defect characteristics, this scaffold-free approach represents a promising avenue for equine practitioners seeking to restore functional articular surfaces.
Read the full abstract on PubMed
Practical Takeaways
- •Scaffold-free SM-MSC constructs represent a promising regenerative medicine option for treating subchondral bone cysts and osteochondral lesions in equine patients, with structural recovery evident within 6 months
- •This technique requires specialized cell culture and expansion capabilities (passage 2-3, >10 million cells) and surgical expertise but could eventually provide an alternative to traditional arthroscopic or surgical management of joint cartilage injuries
- •While results are encouraging in this small series, clinical application would require validation in larger populations and comparison with current standard treatments before routine use in practice
Key Findings
- •Scaffold-free 3D constructs of synovial membrane-derived mesenchymal stem cells successfully regenerated articular cartilage and subchondral bone in femoral medial condyle defects over 6 months
- •Implanted defects showed significantly lower radiolucent volumes compared to control defects at 3 and 6 months post-implantation
- •Modified MOCART scoring and ICRS histological grading demonstrated superior cartilage repair tissue quality in treated versus control osteochondral defects
- •SM-MSCs demonstrated tri-lineage differentiation potential and appropriate immunophenotype (CD44+, CD90+, CD105+, CD34−, CD45−) for regenerative therapy